Manufacturing capacity
OPM Biosciences currently has two cell culture media manufacturing sites,
with future plans for further global expansion.
"We are excited to expand our manufacturing footprint, allowing us to better support our global customers in advancing life-changing therapeutics and shaping the future of healthcare."
Cell Culture Media Manufacturing Facility #1
-
~ 2000 m2 facility
-
Liquid batch size capacity: 400 L / batch
-
Dry power batch size capacity: up to 250 kg / batch
Cell Culture Media Manufacturing Facility #2
-
~ 6000 m2 facility
-
Liquid batch size capacity: up to 2000 L / batch
-
Dry power batch size capacity: up to 2000 kg / batch
End-to-end Biologics CDMO Development Center
-
Focus on drug discovery and development, offering preclinical process development and clinical manufacturing services
-
Equipped with two 200L/500L production lines
-
Customized media solutions, transient transfection platforms
-
Integrated platform for cell line development, process development and antibody quality analysis
-
Scientific support and resources
End-to-end Biologics CDMO Manufacturing Center
-
Focus on manufacturing, offering clinical and commercial manufacturing services
-
Two 2000L production lines, two 500L production lines and two 200L production lines
-
Manufacturing capacity can reach 5400L.
-
Disposable bioreactors reduce risk of cross-contamination, allowing for rapid and flexible production of various products.
